Sponsors (48)
Last progress June 11, 2025 (8 months ago)
Introduced on June 11, 2025 by André Carson
Increases the funding line in the FY2025 continuing appropriations for programs tied to the Congressionally Directed Medical Research Programs (CDMRP) from $40,395,072,000 to $41,576,684,000 (an increase of $1,181,612,000). Directs the Secretary of Defense to implement those CDMRP funds according to the explanatory-statement allocations and priorities and treats the textual change as if it were included in the original law at enactment.
Amend Section 1407(1) of the Full-Year Continuing Appropriations and Extensions Act, 2025 (Public Law 119–4) by striking "$40,395,072,000" and inserting "$41,576,684,000".
Amend Section 1407(1) of Public Law 119–4 by striking the 23rd comma and all that follows through the period at the end and inserting a period (a textual cleanup of that provision).
The amendments made by subsection (a) take effect as if included in the enactment of the Full-Year Continuing Appropriations and Extensions Act, 2025 (Public Law 119–4).
Funds made available for the Congressionally Directed Medical Research Programs (CDMRP) under section 1407(1), as amended, must be implemented in levels and in a manner consistent with the Consolidated Appropriations Act, 2024.
The Secretary of Defense must ensure those funds are used to support all research programs, peer-reviewed initiatives, and projects identified in the explanatory statement accompanying the Consolidated Appropriations Act, 2024.
Who is affected and how:
Overall effect: This is a targeted appropriations adjustment and implementation direction. It does not create new authorities or new ongoing programs but reallocates additional resources within an existing DoD medical-research funding line and requires the Department to follow Congress's stated funding breakdown and priorities when spending the funds.
Referred to the House Committee on Appropriations.